|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMST01160093
|
Anomanolide E
|
|
ST 28:5;O8
|
C28H40O8
|
504.272320
|
|
LMST01160095
|
Anomanolide D
|
|
|
C28H39O8Cl
|
538.233348
|
|
LMST01160096
|
Tubonolide A
|
|
|
C28H39O8Cl
|
538.233348
|
|
LMST01010605
|
22-deoxyInokosterone
|
2beta,3beta,14alpha,20R,26-pentahydroxy-5beta-cholest-7-en-6-one
|
ST 27:2;O6
|
C27H44O6
|
464.313790
|
|
LMST01010606
|
Inokosterone 26-acetate
|
26-acetoxy-2beta,3beta,14alpha,20R,22R-pentahydroxy-5beta-cholest-7-en-6-one
|
ST 29:3;O8
|
C29H46O8
|
522.319270
|
|
LMST01010607
|
Inokosterone 20,22-acetonide
|
20S,22R-acetonide-2beta,3beta,14alpha-trihydroxy-5beta-cholest-7-en-6-one
|
ST 30:3;O7
|
C30H48O7
|
520.340005
|
|
LMST01040290
|
Isocyasterone
|
(22R,24S,25R,28R)-2beta,3beta,14,20,22-pentahydroxy-26,28-epoxy-5beta-stigmast-7-ene-6,26-dione
|
ST 29:4;O8
|
C29H44O8
|
520.303620
|
|
LMST01031347
|
Niuxixinsterone A
|
(20R,22R,24S)-20-O,22-O-(5beta-hydroxymethyl)-furfurylidene-2beta,3beta,14alpha,25-tetrahydroxy-5beta-ergost-7-en-6-one
|
ST 34:6;O9
|
C34H50O9
|
602.345485
|
|
LMST01010608
|
Niuxixinsterone B
|
(20R,22R)-20-O,22-O-(5'-hydroxy-methyl)-furfurylidene-2beta,3beta,25-trihydroxy-14beta-methyl-18-nor-5beta-cholesta-7,12-dien-6-one
|
ST 33:7;O8
|
C33H46O8
|
570.319270
|
|
LMST01031348
|
Niuxixinsterone D
|
(20R,22R,24,25)-20-O,22-O-(5'-hydroxymethyl)-furfurylidene-2beta,3beta,14alpha,26-tetrahydroxy-5beta-cholest-7-en-6-one
|
ST 34:6;O9
|
C34H50O9
|
602.345485
|
|
LMST05030021
|
Glycohyocholic acid
|
N-(3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oyl)-glycine
|
ST 24:1;O4;Gly
|
C26H43NO6
|
465.309039
|
|
LMST05030021
|
Glycohyocholic acid
|
N-(3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oyl)-glycine
|
ST 24:1;O4;Gly
|
C26H43NO6
|
465.309039
|
|
LMST01040291
|
Sengosterone
|
(22R,24S,25S,28R)-2beta,3beta 5beta,14,20,22-hexahydroxy-26,28-epoxy-stigmast-7-ene-6,26-dione
|
ST 29:4;O9
|
C29H44O9
|
536.298535
|
|
LMST01040292
|
28-epi-Sengosterone
|
(22R,24S,25S,28S)-2beta,3beta 5beta,14,20,22-hexahydroxy-26,28-epoxy-stigmast-7-ene-6,26-dione
|
ST 29:4;O9
|
C29H44O9
|
536.298535
|
|
LMST01040293
|
Vernoglabrosterol
|
16beta,23beta-dihydroxy-24beta,28beta-epoxy-stigmasta-3,7-dione
|
ST 29:3;O5
|
C29H46O5
|
474.334525
|
|
LMST01031349
|
|
24-methyl-5alpha-cholesta-7,9(11), 24(28)-trien-3beta-ol
|
ST 28:4;O
|
C28H42O
|
394.323565
|
|
LMST01100066
|
|
14alpha,24S-dimethyl-9beta,19-cyclo-5alpha-cholest-25-en-3beta-ol
|
ST 29:2;O
|
C29H48O
|
412.370515
|
|
LMST01010615
|
20-hydroxyecdysone 3,22-diacetate
|
3beta,22-diacetoxy-2beta,14alpha,20,25-tetrahydroxy-5beta-cholest-7-en-6-one
|
ST 31:4;O9
|
C31H48O9
|
564.329835
|
|
LMST01010614
|
20-hydroxyecdysone 2,22-diacetate
|
2beta, 22-diacetoxy-3beta,14alpha,20,25-tetrahydroxy-5beta-cholest-7-en-6-one
|
ST 31:4;O9
|
C31H48O9
|
564.329835
|
|
LMST01010613
|
22-oxo-20-hydroxyecdysone
|
2beta,3beta,14alpha,20,25-pentahydroxy-5beta-cholest-7-en-6,22-dione
|
ST 27:3;O7
|
C27H42O7
|
478.293055
|
|
LMST02030318
|
3-epi-posterone
|
2beta,3alpha,14alpha-trihydroxy-5β-pregn-7-ene-6,20-dione
|
ST 21:3;O5
|
C21H30O5
|
362.209325
|
|
LMST01010616
|
Alfredensterol
|
2beta,3beta-diacetoxy-22R-hydroxy-5alpha-cholest-7-en-6-one
|
ST 31:4;O6
|
C31H48O6
|
516.345090
|
|
LMST01010617
|
14alpha-hydroxyalfredensterol
|
2beta,3beta-diacetoxy-15alpha,22R-dihydroxy-5alpha-cholest-7-en-6-one
|
ST 31:4;O7
|
C31H48O7
|
532.340005
|
|
LMST01010618
|
3-deacetoxy alfredensterol
|
2beta-acetoxy-3beta,22R-dihydroxy-5alpha-cholest-7-en-6-one
|
ST 29:3;O5
|
C29H46O5
|
474.334525
|
|
LMST03040003
|
Provitamin D5
|
Poriferasta-5,7-dien-3beta-ol
|
|
C29H48O
|
412.370515
|
|
LMST02030319
|
allo-tetrahydrodeoxycortisol
|
3alpha,17,21-trihydroxy-5alpha-pregnan-20-one
|
ST 21:1;O4
|
C21H34O4
|
350.245710
|
|
LMST05050002
|
Ptilosaponoside B
|
4-beta-(3'-sulfo-beta-D-glucopyranosyloxy)-5alpha-pregn-20-en-3beta,19-diol
|
|
C27H44O11S
|
576.260437
|
|
LMST05050004
|
Pandaroside B
|
3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-poriferast-16-ene-15,23-dione
|
|
C35H54O10
|
634.371700
|
|
LMST05050005
|
Pandaroside C
|
3beta-[beta-glucopyranosyl-(1-2)-beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione
|
|
C39H60O15
|
768.393225
|
|
LMST05050006
|
Pandaroside D
|
3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione
|
|
C33H50O10
|
606.340400
|
|
LMST05050006
|
Pandaroside D
|
3beta-[beta-glucopyranosyloxyuronic acid]-16-hydroxy-5alpha,14beta-cholest-16-ene-15,23-dione
|
|
C33H50O10
|
606.340400
|
|
LMST05050007
|
Ximaosteroid D
|
3beta-(2'-O-acetyl-alpha-fucopyranosyloxy)-pregna-5,20-diene
|
|
C29H44O6
|
488.313790
|
|
LMST05050008
|
Evasterioside C
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-24-nor-cholest-22E-en-26-yl sulfate
|
|
C31H52O12S
|
648.317952
|
|
LMST05050008
|
Evasterioside C
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-24-nor-cholest-22E-en-26-yl sulfate
|
|
C31H52O12S
|
648.317952
|
|
LMST05050010
|
Evasterioside E
|
3beta,24S-di-(beta-D-xylopyranosyloxy)-5-alpha-cholestan-6beta,8,15alpha-triol
|
|
C37H64O13
|
716.434695
|
|
LMST05050013
|
Evasterioside B
|
24-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-cholest-22E-en-3-yl sulfate
|
|
C32H54O12S
|
662.333602
|
|
LMST05050013
|
Evasterioside B
|
24-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-cholest-22E-en-3-yl sulfate
|
|
C32H54O12S
|
662.333602
|
|
LMST05050014
|
Kurilensoside E
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-5alpha-cholestan-4beta,8,15alpha,16beta,26-pentol
|
|
C33H58O10
|
614.403000
|
|
LMST05050015
|
Kurilensoside F
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-cholestan-4beta,5alpha,,8,15alpha,16beta,26-hexol
|
|
C33H58O11
|
630.397915
|
|
LMST05050028
|
17-beta-estradiol glucuronide
|
3-hydroxyestra-1,3,5(10)-trien-17beta-yl beta-D-glucopyranosiduronic acid
|
ST 18:3;O2;GlcA
|
C24H32O8
|
448.209720
|
|
LMST05050029
|
Cholesteryl-alpha-D-glucoside
|
Cholest-5-en-3beta-yl alpha-D-glucopyranoside
|
ST 27:1;O;Hex
|
C33H56O6
|
548.407690
|
|
LMST05050033
|
Hesperuside B
|
7-O-(6-O-methyl-beta-D-galactofuranosyl)-16-O-(3-O-methyl-beta-D-galactopyranosyl)-cholest-8(14)-en-3alpha,6beta,7beta,16alphatetrol
|
|
C41H70O14
|
786.476560
|
|
LMST05050035
|
Microdiscusoside A
|
25S-3-O-(beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholesta-4,24(28)-diene-3 beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C38H62O13
|
726.419045
|
|
LMST05050038
|
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,7alpha,8,15alpha,16beta,26-heptaol
|
|
C39H64O15
|
772.424525
|
|
LMST05050039
|
Linckoside I
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C39H64O14
|
756.429610
|
|
LMST05050043
|
Linckoside J
|
(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C32H54O10
|
598.371700
|
|
LMST05050046
|
Linckoside E
|
(24R)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-28-O-(alpha-arabinofuranosyl)-ergosta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C39H66O14
|
758.445260
|
|
LMST05050049
|
Linckoside C
|
3-O-(2-O-methyl-beta-D-xylopyranosyl)-29-O-(beta-D-xylopyranosyl)-28S-methyl-stigmasta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C41H70O14
|
786.476560
|
|
LMST05050051
|
SNAG-delta5-CA
|
3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid
|
|
C32H51NO12S
|
673.313201
|
|
LMST05050051
|
SNAG-delta5-CA
|
3beta-sulfooxy-7beta-N-acetylglucosaminyl-5-cholen-24-oic acid
|
|
C32H51NO12S
|
673.313201
|